Gregory Orloff

Assistant Professor

19922010
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1992 2010

2010

Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-hodgkin lymphoma

Rifkin, R., Spitzer, G., Orloff, G., Mandanas, R., McGaughey, D., Zhan, F., Boehm, K. A., Asmar, L. & Beveridge, R., Jan 1 2010, In : Clinical Lymphoma, Myeloma and Leukemia. 10, 3, p. 186-191 6 p.

Research output: Contribution to journalArticle

Peripheral Blood Stem Cell Transplantation
Neutropenia
Non-Hodgkin's Lymphoma
Carmustine
Erythrocyte Transfusion
2006

Ovarian cancer care: A case study in determined living

Umlauf, R. L. & Orloff, G., Jan 1 2006, In : Onkologie. 29, 1-2, p. 27-29 3 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Hospice Care
Quality of Life
Palliative Care
Therapeutics
2005

Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation

Loren, A. W., Luger, S. M., Stadtmauer, E. A., Tsai, D. E., Schuster, S., Nasta, S. D., Goldstein, S. C., Perl, A., Orloff, G., Oliver, J. C., Green, J., Emerson, S. G. & Porter, D. L., May 1 2005, In : Bone Marrow Transplantation. 35, 9, p. 921-926 6 p.

Research output: Contribution to journalArticle

Unrelated Donors
Stem Cell Transplantation
Graft vs Host Disease
Cyclosporine
Methotrexate
2001

Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

Porter, D. L., Luger, S. M., Duffy, K. M., Stadtmauer, E. A., Laport, G., Schuster, S. J., Orloff, G., Tsai, D., McDaid, K., Kathakali, A., Leonard, D. G. B. & Antin, J. H., Jan 1 2001, In : Biology of Blood and Marrow Transplantation. 7, 4, p. 230-238 9 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Cell- and Tissue-Based Therapy
Recurrence
Chimerism
Graft vs Host Disease
2000

Allogeneic cell therapy (act) after relapse from autologous stem cell transplantation (autosct)

Porter, D., Luger, S., Duffy, K., Orloff, G., Tsai, D., Stadtmauer, E., Laport, G., Schuster, S. & McDaid, K., Dec 1 2000, In : Blood. 96, 11 PART I

Research output: Contribution to journalArticle

Stem Cell Transplantation
Cell- and Tissue-Based Therapy
Stem cells
Chimerism
Tissue Donors
1996

Regulation of interleukin-1β-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins

Durante, W., Kroll, M. H., Orloff, G., Cunningham, J. M., Scott-Burden, T., Vanhoutte, P. M. & Schafer, A. I., Mar 22 1996, In : Biochemical Pharmacology. 51, 6, p. 847-853 7 p.

Research output: Contribution to journalArticle

Nitric Oxide Synthase Type II
Hemostatics
Interleukin-1
Vascular Smooth Muscle
Smooth Muscle Myocytes
1994

Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.

Porter, D. L., Orloff, G. & Antin, J. H., Sep 1 1994, In : Transplantation science. 4, 1, p. 12-14 3 p.

Research output: Contribution to journalArticle

Tumor Virus Infections
Leukocyte Transfusion
Mononuclear Leukocytes
Herpesviridae Infections
Acute Promyelocytic Leukemia
1992

Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line

Lyons, C. R., Orloff, G. & Cunningham, J. M., Jan 1 1992, In : Journal of Biological Chemistry. 267, 9, p. 6370-6374 5 p.

Research output: Contribution to journalArticle

Macrophages
Cloning
Molecular Cloning
Nitric Oxide Synthase Type II
Nitric Oxide Synthase